The global retinal vein occlusion market was valued at USD 2.8 billion in 2023 and is expected to cross USD 5.5 billion by the end of 2034. The industry is projected to grow at a strong CAGR of 6.7% from 2024 to 2034, driven by the rising prevalence of retinal disorders, an aging global population, increasing adoption of advanced anti-VEGF therapies, and improved diagnostic and treatment...